| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.0044 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |